567 related articles for article (PubMed ID: 8894200)
21. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective.
Legge SE; Walters JT
Pharmacogenomics; 2019 Mar; 20(4):279-290. PubMed ID: 30767710
[TBL] [Abstract][Full Text] [Related]
22. Clozapine treatment in Australia: a review of haematological monitoring.
Copolov DL; Bell WR; Benson WJ; Keks NA; Strazzeri DC; Johnson GF
Med J Aust; 1998 May; 168(10):495-7. PubMed ID: 9631674
[TBL] [Abstract][Full Text] [Related]
23. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
Hong X; Wang X
Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
[No Abstract] [Full Text] [Related]
24. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
[No Abstract] [Full Text] [Related]
25. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V
Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
[TBL] [Abstract][Full Text] [Related]
26. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
Majczenko TG; Stewart JT
South Med J; 2008 Jun; 101(6):639-40. PubMed ID: 18475227
[TBL] [Abstract][Full Text] [Related]
27. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.
Ahn YM; Jeong SH; Jang HS; Koo YJ; Kang UG; Lee KY; Kim YS
Int Clin Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 15076018
[TBL] [Abstract][Full Text] [Related]
28. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
[TBL] [Abstract][Full Text] [Related]
29. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
Whiskey E; Taylor D
CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine.
Pantelis C; Adesanya A
Aust N Z J Psychiatry; 2001 Aug; 35(4):544-5. PubMed ID: 11531743
[No Abstract] [Full Text] [Related]
31. Clozapine therapy during cancer treatment.
Rosenstock J
Am J Psychiatry; 2004 Jan; 161(1):175. PubMed ID: 14702271
[No Abstract] [Full Text] [Related]
32. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis.
Honigfeld G
Psychiatr Serv; 1996 Jan; 47(1):52-6. PubMed ID: 8925346
[TBL] [Abstract][Full Text] [Related]
33. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
34. Clozapine-induced agranulocytosis and leukopenia: Incidence, associated factors, and rate of hematologic adverse-effects monitoring in psychiatric out-patient services in Thailand.
Tunsirimas N; Pariwatcharakul P; Choovanichvong S; Ratta-Apha W
Asian J Psychiatr; 2019 Mar; 41():13-16. PubMed ID: 30856469
[TBL] [Abstract][Full Text] [Related]
35. [Ten years of clinical experience with clozapine about 170 patients].
Levoyer D; Martinet JP; Badiche A; Millet B
Encephale; 2004; 30(3):285-95. PubMed ID: 15235527
[TBL] [Abstract][Full Text] [Related]
36. Clozapine-induced agranulocytosis after 11 years of treatment.
Sedky K; Shaughnessy R; Hughes T; Lippmann S
Am J Psychiatry; 2005 Apr; 162(4):814. PubMed ID: 15800170
[No Abstract] [Full Text] [Related]
37. Maximizing clozapine therapy: managing side effects.
Lieberman JA
J Clin Psychiatry; 1998; 59 Suppl 3():38-43. PubMed ID: 9541337
[TBL] [Abstract][Full Text] [Related]
38. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
[TBL] [Abstract][Full Text] [Related]
39. [A case study; ethnicity and clozapine, a risky combination?].
Laan WJ; Ramlal D
Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
[TBL] [Abstract][Full Text] [Related]
40. Granulocytopenia with clozapine and quetiapine.
Diaz P; Hogan TP
Am J Psychiatry; 2001 Apr; 158(4):651. PubMed ID: 11282709
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
